Mereo BioPharma Group plc Director/PDMR Shareholding (6911B)
09 Outubro 2020 - 12:05PM
UK Regulatory
TIDMMPH
RNS Number : 6911B
Mereo BioPharma Group plc
09 October 2020
Mereo BioPharma Group plc
Director and PDMR Dealings
London and Redwood City, Calif ., October 9, 2020 - Mereo
BioPharma Group plc (NASDAQ: MREO, AIM: MPH), "Mereo" or "the
Company", a clinical-stage biopharmaceutical company focused on
oncology and rare diseases, received notification that on October 7
2020 Denise Scots-Knight, Chief Executive Officer of Mereo,
purchased 12,711 American Depositary Shares (ADSs) at a price of
USD 2.36 per ADS, Brian Schwartz, Non-Executive Director of Mereo,
purchased 20,000 ADSs at a price of USD 2.35 per ADS and John
Richard, Head of Corporate Development of Mereo, purchased 6,500
ADSs at a price of USD 2.36 per ADS.
The below announcement and notification is made in accordance
with the EU Market Abuse Regulation. The form required under the EU
Market Abuse Regulation follows.
1 Details of the person discharging managerial responsibilities
a) Name Denise Scots-Knight
------------------------- ----------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------
a) Position/status Chief Executive Officer
------------------------- ----------------------------------------------
b) Initial notification/ Initial notification
Amendment
------------------------- ----------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------
a) Name Mereo BioPharma Group plc
------------------------- ----------------------------------------------
b) LEI 213800U8JQHIJOS5AS09
------------------------- ----------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-------------------------------------------------------------------------
a) Description of MEREO BIOPHARMA GROUP PLC AMERICAN DEPOSITARY
the financial SHARES (ADSs)
instrument, type
of instrument
and identification
code
------------------------- ----------------------------------------------
b) Nature of the PURCHASE
transaction
------------------------- ----------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) USD 2.36 12,711
----------
------------------------- ----------------------------------------------
Aggregated information:
d) volume, Price 30043.72
------------------------- ----------------------------------------------
e) Date of the transaction 2020-10-07
------------------------- ----------------------------------------------
f) Place of the XNMS
transaction
------------------------- ----------------------------------------------
1 Details of the person discharging managerial responsibilities
a) Name Brian Schwartz
------------------------- ----------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------
a) Position/status Non-Executive Director
------------------------- ----------------------------------------------
b) Initial notification/ Initial notification
Amendment
------------------------- ----------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------
a) Name Mereo BioPharma Group plc
------------------------- ----------------------------------------------
b) LEI 213800U8JQHIJOS5AS09
------------------------- ----------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-------------------------------------------------------------------------
a) Description of MEREO BIOPHARMA GROUP PLC AMERICAN DEPOSITARY
the financial SHARES (ADSs)
instrument, type
of instrument
and identification
code
------------------------- ----------------------------------------------
b) Nature of the PURCHASE
transaction
------------------------- ----------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) USD 2.35 20,000
----------
------------------------- ----------------------------------------------
Aggregated information:
d) volume, Price 47068.00
------------------------- ----------------------------------------------
e) Date of the transaction 2020-10-07
------------------------- ----------------------------------------------
f) Place of the XNMS
transaction
------------------------- ----------------------------------------------
1 Details of the person discharging managerial responsibilities
a) Name John Richard
------------------------- ----------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------
a) Position/status Head of Corporate Development
------------------------- ----------------------------------------------
b) Initial notification/ Initial notification
Amendment
------------------------- ----------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------
a) Name Mereo BioPharma Group plc
------------------------- ----------------------------------------------
b) LEI 213800U8JQHIJOS5AS09
------------------------- ----------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-------------------------------------------------------------------------
a) Description of MEREO BIOPHARMA GROUP PLC AMERICAN DEPOSITARY
the financial SHARES (ADSs)
instrument, type
of instrument
and identification
code
------------------------- ----------------------------------------------
b) Nature of the PURCHASE
transaction
------------------------- ----------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) USD 2.36 6,500
----------
------------------------- ----------------------------------------------
Aggregated information:
d) volume, Price 15330.06
------------------------- ----------------------------------------------
e) Date of the transaction 2020-10-07
------------------------- ----------------------------------------------
f) Place of the XNMS
transaction
------------------------- ----------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEKLFBBBLBFBZ
(END) Dow Jones Newswires
October 09, 2020 11:05 ET (15:05 GMT)
Mereo Biopharma (LSE:MPH)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Mereo Biopharma (LSE:MPH)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
